Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension

DRUG6 trials

Sponsors

Alcon Research

Conditions

Ocular HypertensionOpen-Angle GlaucomaOpen-angle Glaucoma

Phase 2

Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination

TerminatedNCT00961649

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2009-10-31End: 2010-02-28Updated: 2013-07-04

A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%

CompletedNCT01426867

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2011-09-30End: 2011-11-30Updated: 2013-07-08

Phase 3

Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%

CompletedNCT01297517

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2011-02-28End: 2012-03-31Updated: 2013-05-21

Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%

CompletedNCT01297920

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2011-03-31End: 2012-06-30Updated: 2013-07-04

Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension

CompletedNCT01310777

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2011-05-31End: 2013-01-31Updated: 2014-03-06

Phase 4

Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®

TerminatedNCT02730871

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2016-06-24End: 2018-07-13Updated: 2019-05-29

Related Papers

Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.

2013-06-0126 citations